SILENCE THERAPEUTICS PLC financial statements, including revenue, expenses, profit, and loss

The total revenue of XRP2 for the last quarter is 1.33 M EUR, and it's 89.29% higher compared to the previous quarter. The net income of Q3 24 is -31.54 M EUR.